BPC-157 is one of the only peptides that can survive in the acidic environment of the stomach, so oral treatment may be very effective
Farveh Yahyapoor, Alireza Sedaghat, Awat Feizi et Mohammad Bagherniya, The effects of l-Carnitine supplementation on inflammatory markers, clinical status, and 28 days mortality in critically ill patients: A double-blind, randomized, placebo-controlled trial , Clinical nutrition ESPEN , vol
Consult a qualified healthcare professional before considering any peptide protocol
However, research on this pentadecapeptide is primarily animal-based and in vitro , with no published full-text clinical studies despite some authors mentioning a phase 1 trial on BPC-157 as an anti-ulcerative agent in IBD patients [6]
Xiong JH, Wang PZ, Son SB, Zhong C, Zhang F, Mao ZQ, Liu ZH, Kim JS